90. Symposium on Advances in Statistical Methods for Cancer Genetic Epidemiology, New York, NY,
August 2013: Statistical modeling of somatic mutation data .
91. Paths of Precision Medicine Symposium, Harvard School of Public Health, Boston, MA, January
2014: Cross-study reproducibility of ovarian cancer signatures.
92. Statistics for the Century of Data, Rutgers University Statistics Symposium, Piscataway, NJ, May
2014: Cross-study Reproducibility of Predictions, with Application to Genomics.
93. IMS Meeting of New Researchers in Statistics and Probability, Harvard University, August 2014:
Cross-study Reproducibility of Predictions, with Application to Genomics.
94. JSM Annual Meeting, Boston, MA, August 2014: Cross-study Reproducibility of Predictions, with
Application to Genomics.
95. Symposium on Statistical and Computational Methods for Pharmacogenetic Epidemiology of Can-
cer, Memorial Sloan Kettering Cancer Center, August 11-12, 2016: Cross-study Analysis of Pre-
diction Algorithms in Genomics.
96. Biostatistics Training Initiative (BTI) Distinguished Lecture, at the Ontario Institute for Cancer
Research (OICR), November 4 2016: Cross-study Analysis of Prediction Algorithms in Genomics.
97. Sackler Colloquia of the National Academy of Sciences, Reproducibility of Research: Issues and
Proposed Remedies, March 10, 2017: New statistical approaches to reproducibility.
98. Big Data in Life Sciences Symposium, Dartmouth College, May 23, 2017: Cross-study analysis of
predictions.
99. Pezcoller Symposium, Trento, Italy, June 22-23, 2017: Novel Approaches to Clinical Trial Design
in Cancer.
Departmental Colloquia
100. Stanford University, Department of Statistics, August 1990:
Optimal Design of Screening Programs.
101. AT&T Bell Laboratories, Statistics Group, September 1990:
Problems in Optimal Scheduling of Inspections.
102. Universit`
a L. Bocconi, Milano, Institute of Quantitative Methods, September 1990:
Problems in Optimal Scheduling of Inspections.
103. University of Pittsburgh, Department of Biostatistics, November 1990:
Optimal Design of Screening Programs.
104. Duke University, Institute of Statistics and Decision Sciences, February 1991:
Optimal Design of Screening Programs.
105. Ohio State University, Department of Statistics, February 1991:
Optimal Design of Screening Programs.
106. Purdue University, Department of Statistics, February 1991:
Optimal Design of Screening Programs.
107. Northwestern University, Department of Statistics, February 1991:
Optimal Design of Screening Programs.
108. Massachusetts Institute of Technology, Sloan School of Management, March 1991:
Optimal Design of Screening Programs.
109. Universit`
a degli Studi di Roma La Sapienza, Istituto di Statistica Probabilit`
a e Statistiche Applicate,
June 1991:
Changes in Utility as Diagnostics.
35
110. CNR-IAMI, Milano, June 1991:
Changes in Utility as Diagnostics.
111. Duke University, Division of Biometry, March 1992:
Optimal Design of Screening Programs.
112. University of Chicago, Graduate School of Business, April 1992:
Optimal Design of Screening Programs.
113. University of North Carolina at Chapel Hill, Department of Biometry, October 1992:
Optimal Screening Ages.
114. Duke University, Division of Biometry, April 1994:
An Overview of Bayesian Tools for Decision Modeling in Medical Guideline Development.
115. University of Minnesota, Department of Statistics and Department of Economics, April 1994:
Stochastic Optimization by Curve Fitting of Monte-Carlo Experiments.
116. University of Pavia, Dipartimento di Economia Politica, May 1994:
Stochastic Optimization by Curve Fitting of Monte-Carlo Experiments.
117. Harvard School of Public Health, Department of Biostatistics, November 1994:
Prediction via Orthogonalized Model Mixing.
118. University of Pavia, Dipartimento di Economia Politica, December 1994:
Prediction via Orthogonalized Model Mixing.
119. University of North Carolina at Chapel Hill, Department of Statistics, January 1995:
Prediction via Orthogonalized Model Mixing.
120. Purdue University, Department of Statistics, January 1996:
Computing the probability of carrying a BRCA1 mutation based on family history.
121. North Carolina State University, Department of Operations Research, April 1996:
Timing Medical Examination via Intensity Functions.
122. Politecnico di Milano, Dipartimento di Matematica e Statistica, June 1996:
Timing Medical Examination via Intensity Functions.
123. Johns Hopkins University, Department of Biostatistics, October 1997:
Determining Carrier Probabilities for Breast Cancer Susceptibility Genes BRCA1 and BRCA2.
124. University of Virginia, Department of Health Evaluation Sciences, March 1998:
Determining Carrier Probabilities for Breast Cancer Susceptibility Genes BRCA1 and BRCA2.
125. Becton Dickinson Technologies, May 1998:
Determining Carrier Probabilities for Breast Cancer Susceptibility Genes BRCA1 and BRCA2.
126. University of Utah, Huntsman Cancer Center, July 1998:
Determining Carrier Probabilities for Breast Cancer Susceptibility Genes BRCA1 and BRCA2.
127. Iowa State University, Department of Statistics, October 1998:
Modeling genetic susceptibility to breast cancer.
128. University of Pennsylvania, Department of Biostatistics and Epidemiology, October 1998:
Modeling genetic susceptibility to breast cancer.
129. University of Pennsylvania, Department of Biostatistics and Epidemiology, February 1999:
Decision Models in Screening for breast cancer.
130. University of Washington, Department of Biostatistics and Department of Statistics, February
1999:
Modeling genetic susceptibility to breast cancer.
131. Iowa State University, Department of Statistics, February 1999:
Bayesian Modeling of Genetic Susceptibility Data in Cancer.
36